Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Dr. Adel Reda, a consultant in Internal Medicine, Endocrinology, and Diabetes at Al-Sabah Hospital, emphasized the importance ...

Covering weight-loss drugs for elderly Americans on the state-backed Medicare health insurance programme would cost the US government $35bn over the next nine years, a congressional analysis has found ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Covering obesity for a decade as a journalist, I’ve interviewed hundreds of patients, following them through diets and bariatric surgeries and on (and sometimes off) weight loss medications.